Difficult asthma

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 58, Issue 2, 2003, Pages 114-121

  Garcia, G ^a   Adler, M ^a   Humbert, M ^a,b  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

^b Serv Pneumol Reanim   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMETABOLITE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUDESONIDE; CHEMOKINE RECEPTOR CCR3; CYCLOSPORIN A; FLUTICASONE; GLUCOCORTICOID; IMMUNOGLOBULIN E ANTIBODY; IMMUNOSUPPRESSIVE AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHOTREXATE; RECEPTOR ANTIBODY;

ASTHMA; BRITTLE ASTHMA; CHURG STRAUSS SYNDROME; DISEASE EXACERBATION; GASTROESOPHAGEAL REFLUX; HUMAN; LUNG ASPERGILLOSIS; LUNG DISEASE; PRIORITY JOURNAL; REVIEW; STEROID THERAPY;

ANTI-ASTHMATIC AGENTS; ASTHMA; DISEASE MANAGEMENT; GLUCOCORTICOIDS; HUMANS; PREVALENCE; RISK FACTORS; TREATMENT FAILURE;

EID: 0037303647     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2003.02171.x     Document Type: Review

References (86)

1. Guidelines for management of asthma. BMJ 1990;301:651-653.
2. CHUNG KF, GODARD P, ADELROTH E, et al. ERS TASK FORCE ON DIFFICULT/THERAPY-RESISTANT ASTHMA. Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. European Respiratory Society. Eur Respir J 1999;13:1198-1208.
3. BUSSE WW. Inflammation in asthma: the cornerstone of the disease and target of therapy. J Allergy Clin Immunol 1998;102:S17-S22.
4. BOUSQUET J. Global initiative for asthma (GINA) and its objectives. Clin Exp Allergy 2000;30:2-5.
5. BANERJEE DK, LEE GS, MALIK SK, DALY S. Underdiagnosis of asthma in the elderly. Br J Dis Chest 1987;81:23-29.
6. BURROWS B, BARBEE RA, CLINE MG, KNUDSON RJ, LEBOWITZ MD. Characteristics of asthma among elderly adults in a sample of the general population. Chest 1991;100:935-942.
7. CABANES LR, WEBER SN, MATRAN R, et al. Bronchial hyperresponsiveness to methacholine in patients with impaired left ventricular function. N Engl J Med 1989;320:1317-1322.
8. BURROWS B, LEBOWITZ MD, BARBEE RA, CLINE MG. Findings before diagnoses of asthma among the elderly in a longitudinal study of a general population sample. J Allergy Clin Immunol 1991;88:870-877.
9. DOW I, HOLGATE ST. Assessment and treatment of obstructive airways disease in the elderly. Br Med Bull 1990;46:230-245.
10. TUUPONEN T, KEISTINEN T, KIVELA SL. Hospital admissions for asthma in Finland during 1972-86 of adults aged 65 years and over. Age Ageing 1993;22:96-102.
11. ROBIN ED. Death from bronchial asthma. Chest 1988;93:614-618.
12. SLY RM. Increases in deaths from asthma. Ann Allergy 1984;53:20-25.
13. SMYTH ET, WRIGHT SC, EVANS AE, SINNAMON DG, MACMAHON J. Death from airways obstruction: accuracy of certification in Northern Ireland. Thorax 1996;51:293-297.
14. FABBRI L, BEGHE B, CARAMORI G, PAPI A, SAETTA M. Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease. Thorax 1998;53:803-808.
15. POSTMA DS, KERSTJENS HA. Characteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:S187-S192.
16. CHRISTOPHER KL, WOOD RP, ECKERT RC, BLAGER FB, RANEY RA, SOUHRADA JF. Vocal-cord dysfunction presenting as asthma. N Engl J Med 1983;308:1566-1570.
17. NEWMAN KB, MASON UG, SCHMALING KB. Clinical features of vocal cord dysfunction. Am J Respir Crit Care Med 1995;152:1382-1386.
18. THOMAS PS, GEDDES DM, BARNES PJ. Pseudo-steroid resistant asthma. Thorax 1999;54:352-356.
19. NAHMIAS J, TANSEY M, KARETZKY MS. Asthmatic extrathoracic upper airway obstruction: laryngeal dyskinesis. N J Med 1994;91:616-620.
20. GAVIN LA, WAMBOLDT M, BRUGMAN S, ROESLER TA, WAMBOLDT F. Psychological and family characteristics of adolescents with vocal cord dysfunction. J Asthma 1998;35:409-417.
21. COCHRANE GM. Therapeutic compliance in asthma; its magnitude and implications. Eur Respir J 1992;5:122-124.
22. TEETER JG, BLEECKER ER. Relationship between airway obstruction and respiratory symptoms in adult asthmatics. Chest 1998;113:272-277.
23. JUNIPER EF, O'BYRNE PM, FERRIE PJ, KING DR, ROBERTS JN. Measuring asthma control. Clinic questionnaire or daily diary? Am J Respir Crit Care Med 2000;162:1330-1334.
24. SIMPSON WG. Gastroesophageal reflux disease and asthma. Diagnosis Manage Arch Intern Med 1995;155:798-803.
25. GUILL MF. Respiratory manifestations of gastroesophageal reflux in children. J Asthma 1995;32:173-189.
26. SCHINDLBECK NE, HEINRICH C, KONIG A, DENDORFER A, PACE F, MULLER-LISSNER SA. Optimal thresholds, sensitivity, and specificity of long-term pH-metry for the detection of gastroesophageal reflux disease. Gastroenterology 1987;93:85-90.
27. FIELD SK, UNDERWOOD M, BRANT R, COWIE RL. Prevalence of gastroesophageal reflux symptoms in asthma. Chest 1996;109:316-322.
28. IRWIN RS, FRENCH CL, CURLEY FJ, ZAWACKI JK, BENNETT FM. Chronic cough due to gastroesophageal reflux. Clinical, diagnostic, and pathogenetic aspects. Chest 1993;104:1511-1517.
29. FIELD SK, SUTHERLAND LR. Does medical antireflux therapy improve asthma in asthmatics with gastroesophageal reflux? A critical review of the literature. Chest 1998;114:275-283.
30. BOEREE MJ, PETERS FT, POSTMA DS, KLEIBEUKER JH. No effects of high-dose omeprazole in patients with severe airway hyperresponsiveness and (a) symptomatic gastro-oesophageal reflux. Eur Respir J 1998;11:1070-1074.
31. EKSTROM T, LINDGREN BR, TIBBLING L. Effects of ranitidine treatment on patients with asthma and a history of gastro-oesophageal reflux: a double blind crossover study. Thorax 1989;44:19-23.
32. PERRIN-FAYOLLE M, GORMAND F, BRAILLON G, et al. Long-term results of surgical treatment for gastroesophageal reflux in asthmatic patients. Chest 1989;96:40-45.
33. JOHANSSON SGO, HOURIHANE JO'B, BOUSQUET J, et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56:813-824.
34. LUND VJ, KENNEDY DW. THE STAGING THERAPY GROUP. Quantification for staging sinusitis. Ann Otol Rhinol Laryngol Suppl 1995;167:17-21.
35. BOUSQUET J, VAN CAUWENBERGE P, KHALTAEV N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108:S147-S334.
36. HUGHES RG, JONES NS. The role of nasal endoscopy in outpatient management. Clin Otolaryngol 1998;23:224-226.
37. BHATTACHARYYA T, PICCIRILLO J, WIPPOLD FJ. Relationship between patient-based descriptions of sinusitis and paranasal sinus computed tomographic findings. Arch Otolaryngol Head Neck Surg 1997;123:1189-1192.
38. AUBIER M, LEVY J, CLERICI C, NEUKIRCH F, HERMAN D. Different effects of nasal and bronchial glucocorticosteroid administration on bronchial hyperresponsiveness in patients with allergic rhinitis. Am Rev Respir Dis 1992;146:122-126.
39. LAMBLIN C, GOSSET P, SALEZ F, et al. Eosinophilic airway inflammation in nasal polyposis. J Allergy Clin Immunol 1999;104:85-92.
40. LILDHOLDT T, RUNDCRANTZ H, LINDQVIST N. Efficacy of topical corticosteroid powder for nasal polyps: a double-blind, placebo-controlled study of budesonide. Clin Otolaryngol 1995;20:26-30.
41. LAMBLIN C, BRICHET A, PEREZ T, DARRAS J, TONNEL AB, WALLAERT B. Long-term follow-up of pulmonary function in patients with nasal polyposis. Am J Respir Crit Care Med 2000;161:406-413.
42. INNES NJ, REID A, HALSTEAD J, WATKIN SW, HARRISON BD. Psychosocial risk factors in near-fatal asthma and in asthma deaths. J R Coll Physicians Lond 1998;32:430-434.
43. CAMPBELL DA, YELLOWLEES PM, MCLENNAN G, et al. Psychiatric and medical features of near fatal asthma. Thorax 1995;50:254-259.
44. JOSEPH KS, BLAIS L, ERNST P, SUISSA S. Increased morbidity and mortality related to asthma among asthmatic patients who use major tranquillisers. BMJ 1996;312:79-82.
45. KENDRICK AH, HIGGS CM, WHITFIELD MJ, LASZLO G. Accuracy of perception of severity of asthma: patients treated in general practice. BMJ 1993;307:422-424.
46. NEUKIRCH C, HENRY C, LEYNAERT B, LIARD R, BOUSQUET J, NEUKIRCH F. Is sensitization to Alternaria alternata a risk factor for severe asthma? A population-based study. J Allergy Clin Immunol 1999;103:709-711.
47. CALL RS, WARD G, JACKSON S, PLATTS-MILLS TA. Investigating severe and fatal asthma. J Allergy Clin Immunol 1994;94:1065-1072.
48. KOGEVINAS M, ANTO JM, SUNYER J, TOBIAS A, KROMHOUT H, BURNEY P. EUROPEAN COMMUNITY RESPIRATORY HEALTH SURVEY STUDY GROUP. Occupational asthma in Europe and other industrialised areas: a population-based study. Lancet 1999;353:1750-1754.
49. CHAN-YEUNG M, MALO JL. Occupational asthma. N Engl J Med 1995;333:107-112.
50. PEDERSEN B, DAHL R, KARLSTROM R, PETERSON CG, VENGE P. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking. Am J Respir Crit Care Med 1996;153:1519-1529.
51. AYRES JG, MILES JF, BARNES PJ. Brittle asthma. Thorax 1998;53:315-321.
52. MILES J, CAYTON R, AYRES J. Atopic status in patients with brittle and non-brittle asthma: a case-control study. Clin Exp Allergy 1995;25:1074-1082.
53. MILES JF, GARDEN GM, TUNNICLIFFE WS, CAYTON RM, AYRES JG. Psychological morbidity and coping skills in patients with brittle and non-brittle asthma: a case-control study. Clin Exp Allergy 1997;27:1151-1159.
54. GARDEN GM, AYRES JG. Psychiatric and social aspects of brittle asthma. Thorax 1993;48:501-505.
55. KOLBE J, FERGUSSON W, GARRETT J. Rapid onset asthma: a severe but uncommon manifestation. Thorax 1998;53:241-247.
56. LOZA C, BROSTOFE J. Peanut allergy. Clin Exp Allergy 1995;25:493-502.
57. BEYNON HL, GARBETT ND, BARNES PJ. Severe premenstrual exacerbations of asthma: effect of intramuscular progesterone. Lancet 1988;2:370-372.
58. PAULI BD, REID RL, MUNT PW, WIGLE RD, FORKERT L. Influence of the menstrual cycle on airway function in asthmatic and normal subjects. Am Rev Respir Dis 1989;140:358-362.
59. BARNES PJ, GREENING AP, CROMPTON GK. Glucocorticoid resistance in asthma. Am J Respir Crit Care Med 1995;152:S125-S140.
60. WOOLCOCK AJ. Steroid resistant asthma: what is the clinical definition? Eur Respir J 1993;6:743-747.
61. LANE SJ. Pathogenesis of steroid-resistant asthma. Br J Hosp Med 1997:57:394-398.
62. LANE SJ, LEE TH. Mechanisms of corticosteroid resistance in asthmatic patients. Int Arch Allergy Immunol 1997;113:193-195.
63. HAMID QA, WENZEL SE, HAUK PJ, et al. Increased glucocorticoid receptor beta in airway cells of glucocorticoid-insensitive asthma. Am J Respir Crit Care Med 1999;159:1600-1604.
64. CORRIGAN CJ, BROWN PH, BARNES NC, TSAI JJ, FREW AJ, KAY AB. Glucocorticoid resistance in chronic asthma. Peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoids and cyclosporin A. Am Rev Respir Dis 1991;144:1026-1032.
65. LANGE P, PARNER J, VESTBO J, SCHNOHR P, JENSEN G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998;339:1194-1200.
66. VIGNOLA AM, GRUTTA SL, CHIAPPARA G, BENKEDER A, BELLIA V, BONSIGNORE G. Cellular network in airways inflammation and remodelling. Paediatr Respir Rev 2002;3:41-46.
67. BLACK JL, JOHNSON PR. Factors controlling smooth muscle proliferation and airway remodelling. Curr Opin Allergy Clin Immunol 2002;2:47-51.
68. STEVENS DA, SCHWARTZ HJ, LEE FY, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000;342:756-762.
69. SALEZ F, BRICHET A, DESURMONT S, GROSBOIS JM, WALLAERT B, TONNEL AB. Effects of itraconazole therapy in allergic bronchopulmonary aspergillosis. Chest 1999;116:1665-1668.
70. COTTIN V, CORDIER JF. Churg-Strauss syndrome. Allergy 1999;54:535-551.
71. LE GALL C, PHAM S, VIGNES S, et al. Inhaled corticosteroids and Churg-Strauss syndrome: a report of five cases. Eur Respir J 2000;15:978-981.
72. MILGROM H, BENDER B, ACKERSON L, BOWRY P, SMITH B, RAND C. Non-compliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996;98:1051-1057.
73. MILGROM H, WAMBOLDT F, BENDER B. Monitoring adherence to the therapy of asthma. Curr Opin Allergy Clin Immunol 2002;2:201-205.
74. WILSON SR, SCAMAGAS P, GERMAN DF, et al. A controlled trial of two forms of self-management education for adults with asthma. Am J Med 1993;94:564-576.
75. DAHL R, LUNDBACK B, MALO JL, et al. A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. Int Study Group Chest 1993;104:1352-1358.
76. BUSSE WW, CHERVINSKY P, CONDEMI J, et al. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma. J Allergy Clin Immunol 1998;101:457-463.
77. GREENING AP, IND PW, NORTHFIELD M, SHAW G. ALLEN HANBURYS LIMITED UK STUDY GROUP. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994;344:219-224.
78. WOOLCOCK A, LUNDBACK B, RINGDAL N, JACQUES LA. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996;153:1481-1488.
79. PAUWELS RA, LOFDAHL CG, POSTMA DS, et al. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997;337:1405-1411.
80. REISS TF, CHERVINSKY P, DOCKHORN RJ, SHINGO S, SEIDENBERG B, EDWARDS TB. MONTELUKAST CLINICAL RESEARCH STUDY GROUP. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Arch Intern Med 1998;158:1213-1220.
81. TAMAOKI J, KONDO M, SAKAI N, et al. THE TOKYO JOSHI-IDAI ASTHMA RESEARACH GROUP. Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. Am J Respir Crit Care Med 1997;155:1235-1240.
82. ROBINSON DS, CAMPBELL D, BARNES PJ. Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial. Lancet 2001;357:2007-2011.
83. LOCK SH, KAY AB, BARNES NC. Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma. Am J Respir Crit Care Med 1996;153:509-514.
84. ALEXANDER AG, BARNES NC, KAY AB. Trial of cyclosporin in corticosteroid-dependent chronic severe asthma. Lancet 1992;339:324-328.
85. MILGROM H, FICK RB JR., SU JQ, et al. RHUMAB-E25 STUDY GROUP. Treatment of allergic asthma with monoclonal anti-IgE antibody. N Engl J Med 1999;341:1966-1973.
86. MILGROM H, BERGER W, NAYAK A, et al. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab). Pediatrics 2001;108:E36.